Medication adherence: emerging use of technology
BB Granger, HB Bosworth - Current opinion in cardiology, 2011 - journals.lww.com
Integration of in-person contacts with technology-driven medication adherence reminders,
electronic medication reconciliation, and pharmaceutical databases may improve …
electronic medication reconciliation, and pharmaceutical databases may improve …
Gender-related factors in medication adherence for metabolic and cardiovascular health
V Venditti, E Bleve, S Morano, T Filardi - Metabolites, 2023 - mdpi.com
This review explores the impact of gender on medication adherence in the context of
metabolic and cardiovascular diseases. Optimal adherence to medication is crucial for …
metabolic and cardiovascular diseases. Optimal adherence to medication is crucial for …
Non-adherence in type 2 diabetes: practical considerations for interpreting the literature
DF Blackburn, J Swidrovich… - Patient preference and …, 2013 - Taylor & Francis
The rising prevalence of type 2 diabetes poses a serious threat to human health and the
viability of many health care systems around the world. Although several prescription …
viability of many health care systems around the world. Although several prescription …
Determinants of adherence to heart failure medication: a systematic literature review
R Oosterom-Calo, AJ Van Ballegooijen, CB Terwee… - Heart failure …, 2013 - Springer
A systematic literature review was conducted to summarize the existing evidence on
presumed determinants of heart failure (HF) medication adherence. The aim was to assess …
presumed determinants of heart failure (HF) medication adherence. The aim was to assess …
Medication initiation burden required to comply with heart failure guideline recommendations and hospital quality measures
Background—Guidelines for heart failure (HF) recommend prescription of guideline-directed
medical therapy before hospital discharge; some of these therapies are included in publicly …
medical therapy before hospital discharge; some of these therapies are included in publicly …
Heart failure in north america
Heart failure is a major health problem that affects patients and healthcare systems
worldwide. Within the continent of North America, differences in economic development …
worldwide. Within the continent of North America, differences in economic development …
Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients
S Scalvini, P Bernocchi, S Villa, AM Paganoni… - International Journal of …, 2021 - Elsevier
Background This study evaluates, in a real-world setting, to what extent the recommended
therapies by international guidelines, are prescribed after a first hospitalization for heart …
therapies by international guidelines, are prescribed after a first hospitalization for heart …
Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis
M Lemstra, MW Alsabbagh - Patient preference and adherence, 2014 - Taylor & Francis
Purpose The World Health Organization (WHO) concluded that poor adherence to treatment
is the most important cause of uncontrolled high blood pressure, with approximately 75% of …
is the most important cause of uncontrolled high blood pressure, with approximately 75% of …
The pharmacist role in predicting and improving medication adherence in heart failure patients
EM Davis, KA Packard, CA Jackevicius - Journal of Managed Care …, 2014 - jmcp.org
BACKGROUND: Heart failure is one of the most common reasons for hospital admissions in
patients aged 65 years and older, with an estimated 1 million hospitalizations annually. In …
patients aged 65 years and older, with an estimated 1 million hospitalizations annually. In …
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014–2020
KM Ødegaard, SS Lirhus, HO Melberg… - ESC Heart …, 2023 - Wiley Online Library
Aims We aimed to study initiation, adherence, and long‐term persistence to beta‐blockers
(BB), renin–angiotensin system inhibitors (RASi), and mineralocorticoid receptor antagonists …
(BB), renin–angiotensin system inhibitors (RASi), and mineralocorticoid receptor antagonists …